WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (157)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.

 Previous Article  |  Next Article 

Volume 17, Number 15, Issue of August 1, 1997 pp. 5747-5759
Copyright ©1997 Society for Neuroscience

Influence of Subunit Composition on Desensitization of Neuronal Acetylcholine Receptors at Low Concentrations of Nicotine

Catherine P. Fenster1, 2, M. Felicia Rains1, Brett Noerager2, Michael W. Quick1, 2, and Robin A. J. Lester1, 2

Departments of 1 Neurobiology and 2 Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The influence of alpha  and beta  subunits on the properties of nicotine-induced activation and desensitization of neuronal nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes was examined. Receptors containing alpha 4 subunits were more sensitive to activation by nicotine than alpha 3-containing receptors. At low concentrations of nicotine, nAChRs containing beta 2 subunits reached near-maximal desensitization more rapidly than beta 4-containing receptors. The concentration of nicotine producing half-maximal desensitization was influenced by the particular alpha  subunit expressed; similar to results for activation, alpha 4-containing receptors were more sensitive to desensitizing levels of nicotine than alpha 3-containing receptors. The alpha  subunit also influenced the rate of recovery from desensitization; this rate was approximately inversely proportional to the apparent nicotine affinity for the desensitized state. The homomeric alpha 7 receptor showed the lowest sensitivity to nicotine for both activation and desensitization; alpha 7 nAChRs also demonstrated the fastest desensitization kinetics. These subunit-dependent properties remained in the presence of external calcium, although subtle, receptor subtype-specific effects on both the apparent affinities for activation and desensitization and the desensitization kinetics were noted. These data imply that the subunit composition of various nAChRs determines the degree to which receptors are desensitized and/or activated by tobacco-related levels of nicotine. The subtype-specific balance between receptor activation and desensitization should be considered important when the cellular and behavioral actions of nicotine are interpreted.

Key words: nicotinic receptor subtypes; nicotine addiction; ion channel; CNS; desensitization; regulation; Xenopus oocytes; calcium ions; synaptic transmission


INTRODUCTION

Neuronal nicotinic receptors (nAChRs) are a functionally diverse group of ligand-gated ion channels formed from the pentameric arrangement of one or more individual subunits (Couturier et al., 1990; Anand et al., 1991; Cooper et al., 1991; Luetje and Patrick, 1991). The existence of multiple subtypes (Role, 1992), their nonuniform distribution within the CNS (Duvoisin et al., 1989; Wada et al., 1989; Morris et al., 1990; Whiting et al., 1991; Dineley-Miller and Patrick, 1992; Seguela et al., 1993), and their localization to both pre- and postsynaptic zones (Clark, 1993; McGehee and Role, 1996; Role and Berg, 1996; Wonnacott, 1997) imply diverse functions of nAChRs and suggest that several mechanisms are involved in the behaviorally important actions of nicotine.

At a minimum, any cellular and molecular theory of nicotine dependency must take into account that nAChRs can be both activated and desensitized by nicotine (Katz and Thesleff, 1957). Much evidence supports the idea that each of these receptor states is critical in addiction (Stolerman and Shoaib, 1991; Dani and Heinemann, 1996). Because these receptor states vary according to subunit composition (Cachelin and Jaggi, 1991; Gross et al., 1991; Hsu et al., 1995; Vibat et al., 1995), subtypes of nAChRs may be involved differentially in the acute and chronic effects of nicotine and their associated cellular compensatory events (Balfour, 1994). These include subtype-specific increases in receptor number within various brain regions (Marks et al., 1992). Moreover, the extent to which nAChR subtypes are activated and desensitized by nicotine could determine whether specific receptor subtypes are functionally up- (Rowell and Wonnacott, 1990; Gopalakrishnan et al., 1996) or downregulated (Marks et al., 1993) during chronic agonist exposure (Hsu et al., 1995).

Although the actual subunit composition of native CNS nAChRs is unknown, many expressed receptor subtypes (Whiting and Lindstrom, 1988; Flores et al., 1992; Anand et al., 1993) share characteristics of CNS nAChRs. Thus, understanding the influences of different subunits on receptor function has value both for determining dominant subunits in native receptors and for predicting the effects of nicotine on nAChRs composed of particular subunits. Previous studies have addressed how subunit composition affects the time course of desensitization and the agonist potency for activation (Cachelin and Jaggi, 1991; Gross et al., 1991; Luetje and Patrick, 1991; Cohen et al., 1995; Hsu et al., 1995; Vibat et al., 1995). However, many of these studies used acetylcholine as the principal agonist. Because agonists can affect desensitization differentially, it is not possible to predict accurately how nicotine will interact with desensitized states of nAChRs. Moreover, except for one report (Hsu et al., 1995), desensitization has not been characterized using low, tobacco-related concentrations of nicotine (Benowitz et al., 1989). In the present study we evaluate the action of low concentrations of nicotine on both activation and desensitization of a number of nAChRs expressed in Xenopus oocytes and examine the contribution of both alpha  and beta  subunits to these processes.


MATERIALS AND METHODS

Xenopus oocyte preparation and cRNA injection. Procedures for preparation of oocytes have been described in detail elsewhere (Quick and Lester, 1994). Briefly, oocytes were defolliculated and maintained at 18°C in incubation medium containing ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES, pH 7.4), 1.8 or 3.6 mM CaCl2, 50 µg/ml gentamycin, and 5% horse serum. Subunit cRNAs were synthesized in vitro (Machine Message; Ambion, Austin, TX) from linearized plasmid templates of rat cDNA clones. Oocytes were injected with between 5 and 25 ng/subunit per oocyte; alpha  and beta  subunit cRNAs were injected in 1:1 ratios, although in some experiments in which alpha 3beta 4 receptors were examined, cRNAs ratios of 10:1 alpha 3:beta 4 and 1:10 alpha 3:beta 4 were injected. All salts and drugs were obtained from Sigma (St. Louis, MO).

Electrophysiology. Whole-cell currents were measured at room temperature (20-25°C), 24-96 hr postinjection, with a Geneclamp 500 amplifier (Axon Instruments, Foster City, CA) in a standard two-microelectrode voltage-clamp configuration. Electrodes were filled with 3 M KCl and had resistances of ~0.5-2 MOmega . Oocytes were clamped between -40 and -60 mV and superfused continuously in calcium-free ND96 (i.e., nominally calcium-free solution) or in the presence of 3.6 mM calcium (i.e., calcium-containing solutions). This concentration of calcium is in the middle of the range for potentiation of nAChRs responses (Mulle et al., 1992b; Vernino et al., 1992). For comparison, the effects of 1.8 and 3.6 mM calcium were examined on alpha 7 receptors. All drugs were applied in these solutions. (-)-Nicotine tartrate (nicotine) and acetylcholine chloride (acetylcholine) were prepared from frozen stock solutions (100 mM). Atropine (1 µM) was included in the superfusion solution to block endogenous muscarinic responses. All currents were recorded either on a chart recorder and/or on an 80486-based personal computer with AxoScope software (Axon Instruments) after 50-100 Hz low-pass filtering at a digitization frequency of 200 Hz. For slowly desensitizing responses, peak currents were assessed on-line from the digital readout of the amplifier and/or off-line with AxoScope software.

Peak currents at EC50 concentrations were typically in the range of 100 nA-2 µA. Currents as small as 5 nA could be measured, although for accuracy only currents above 20 nA were included in the desensitization measurements. Concentration-response curves were fit with logistic expressions to estimate the EC50 (activation) and IC50 (desensitization). Single and/or double exponential fits of the data were used to compare the time courses of desensitization and recovery. Exponential curves were fit either to the desensitizing phase of the nAChR responses or to the time course of desensitization development as assessed from the depression of test pulses applied during incubation with nicotine. In both cases exponentials were constrained not to fall below zero current. For some nAChR subtypes, recovery from desensitization could be slow (>1 hr) and often was incomplete before the recording became unstable. For these data the exponential fits were constrained to allow full recovery back to control values.

Solutions were gravity-fed via a six-way manual valve (Rainin Instruments, Woburn, MA) to the oocyte in the recording chamber; some solution mixing occurred in the dead space between the valve and the chamber. To estimate the effect of dead space on the agonist application, we calculated the solution exchange rate from the time course of inhibition of the current induced by nicotine (5 µM) through beta 4 subunit-containing receptors during a step from medium containing 96 mM NaCl to one containing 48 mM NaCl (96 mM sucrose was used to restore osmolality). The time constant for the exchange, obtained from a single exponential fit, was 1.3 ± 0.3 sec (10 observations from five different oocytes). Thus, solution exchange was complete within ~5 sec. Because of this noninstantaneous exchange, at high agonist concentrations and in particular for alpha 7 nAChRs that desensitize very rapidly, true peak currents are underestimated. This may result in an overestimation of the EC50 for activation and a smaller Hill coefficient. Although this is a potential problem in certain types of analyses, in the present study we were concerned for the most part with activation and desensitization at relatively low agonist concentrations in which the influence of exchange rate is less critical. All data are expressed as the mean ± SEM. For statistical comparisons of concentration-response curves, t tests were performed on the regression coefficients, estimated by using the method of probits (Finney, 1971). For statistical comparisons of mean data, weighted means t tests were performed for all unpaired comparisons.


RESULTS

Potency of nicotine for activation of nAChRs

The differential sensitivity of nicotine in activating various expressed receptors (Luetje and Patrick, 1991) implies that nicotine is not equipotent at all nAChRs. Nicotine-induced concentration-response relationships for four different expressed nAChRs (alpha 3beta 4, alpha 3beta 2, alpha 4beta 4, and alpha 4beta 2) confirm this hypothesis (Fig. 1). Logistic fits to these concentration-response curves estimate EC50 values that can be divided into two groups (Table 2): receptors containing alpha 4 subunits have lower EC50 values than those containing alpha 3 subunits (t = 13.27; p < 0.01), implying that alpha 4 subunits confer a higher apparent nicotine affinity. Because of the high permeability of various neuronal nAChRs to calcium (Mulle et al., 1992a; Vernino et al., 1992; Seguela et al., 1993; Rathouz and Berg, 1994) and the potential contamination of the measured currents with the activation of oocyte endogenous calcium-dependent Cl- currents (Vernino et al., 1992), the above series of experiments was conducted in nominally calcium-free media. Physiologically relevant levels of calcium can, however, regulate nAChR activation, an effect that may result, in part, from changes in the affinity of nAChRs for agonist (Mulle et al., 1992b; Vernino et al., 1992; Galzi et al., 1996). To ascertain that the observed differences in the nAChR concentration-response relationships in calcium-free solutions were physiologically important, we repeated the experiments in calcium-containing media. The addition of calcium produced insignificant changes in EC50 values (t = 0.35; p > 0.05) and did not alter the order of potency of nicotine for the various nAChR subtypes (Table 1).
Fig. 1. alpha 4 subunits confer high apparent affinity on nAChRs. A, Concentration-response curves were constructed by measuring the peak current induced in response to brief (5-10 sec) applications of nicotine (100 nM-300 µM). The peak responses are plotted with respect to agonist concentration for four subtypes of nAChRs (alpha 3beta 4, alpha 3beta 2, alpha 4beta 4, and alpha 4beta 2). For each subtype all responses were normalized to a response near the half-maximal concentration (EC50). Each point represents one to eight separate measurements. The solid lines are logistic fits to the data. The calculated EC50 values and the Hill coefficients were, respectively, 65 µM and 1.5 (alpha 3beta 4), 75 µM and 0.7 (alpha 3beta 2), 11 µM and 1.4 (alpha 4beta 4), and 12 µM and 1.5 (alpha 4beta 2). B, Representative current responses for a series of nicotine concentrations applied to two different oocytes expressing either alpha 3beta 4 receptors (top traces) or alpha 4beta 4 receptors (bottom traces). All data shown in this figure were obtained in calcium-free conditions.
[View Larger Version of this Image (15K GIF file)]

Table 2. Calcium dependence of nAChR desensitization


Subtype  tau slow (sec)
 tau fast (sec)
Fast component (%)
Fraction of cells with fast component
+Ca  -Ca +Ca  -Ca +Ca  -Caa +Ca  -Ca

 alpha 4beta 4 129.8  ± 20.2 123.7  ± 9.9 3.2  ± 1.1 N/A 13.6  ± 9.2 N/A 2 /5 0 /5
 alpha 4beta 2 90.7  ± 5.9 102.5  ± 20.0 5.4  ± 1.5 7.4  ± 1.4 40.3*  ± 3.2 11.3  ± 6.1 3 /3 2 /3
 alpha 3beta 4b 204.6  ± 25.4 147.4  ± 14.1 3.7*  ± 0.7 11.3  ± 0.9 21.8  ± 3.7 18.5  ± 3.5 6 /11 2 /11
 alpha 3beta 2 279.6  ± 224.5 66.8  ± 16.2 8.0  ± 1.5 11.3  ± 1.7 46.3*  ± 8.6 66.8  ± 1.0 4 /4 4 /4

All data were obtained from oocytes that were measured in both calcium-free (-Ca) and calcium-containing (+Ca) media. a The mean percentage of fast component includes only those oocytes that had a measurable fast component. b In some oocytes the two desensitization components were fit separately (see Fig. 2). * Indicates significance (p < 0.05), as compared with data obtained in calcium-free media.

Table 1. Subunit-specific properties of nAChRs


Subtype EC50aM)
IC50bM) ±Ca Desensitization at 500 nM (%) ±Ca Desensitization time coursec (tau d; min)
Desensitization recoveryd (tau ; min) ±Ca
+Ca  -Ca +Ca  -Ca

 alpha 3beta 4 62 65 1.15 39 32.5  ± 2.5 (3) 36.8  ± 4.8  (7) 42.6  ± 5.5  (4)
 alpha 4beta 4 9 11 0.042 87 35.5*  ± 3.2 (5) 16.2  ± 2.8  (3) 413.8f  ± 305.5  (2)
 alpha 3beta 2 123 75 0.33 47  approx 5 (3)e 3.9  ± 2.1  (4) 11.7  ± 4.1  (2)
 alpha 4beta 2 15 12 0.061 71 3.7  ± 0.9 (4) 2.7  ± 0.3  (2) 86.9  ± 64.7  (4)
 alpha 7 90* 234 6.2  (-Ca) 1  (-Ca) 0.5  ± 0.03 (3) 1.9  ± 0.5  (4) 1.9  ± 0.5  (5)
1.3* (+Ca) 12  (+Ca)

a EC50 calculated from the activation concentration-response curve in calcium-containing (+Ca) and calcium-free (-Ca) media. b IC50 calculated from the concentration-response curves constructed from the mean desensitization produced in both +Ca and -Ca media. These combined data are indicated by ±Ca. c The time constant (tau d) from a single exponential fit to the time course of desensitization at near IC50 concentrations of nicotine. These concentrations were 1 µM (alpha 3beta 4), 100 nM (alpha 4beta 4), 300 nM (alpha 3beta 2), 300 nM (alpha 4beta 2), 10 µM (-Ca, alpha 7), and 3 µM (+Ca, alpha 7). The number of measurements is indicated in parentheses. d The time constant (tau ) from a single exponential fit to the time course of recovery from desensitization at 1 µM nicotine for all subtypes except alpha 7 (10 µM). The number of measurements is indicated in parentheses. In the majority of experiments, the exponential was fit by assuming full recovery to control values. e The reported values are estimates. It was difficult to obtain an accurate exponential fit for some of the alpha 3beta 2 data sets, because the interpulse interval for the test pulses was large (5-10 min) and desensitization mainly was complete by the time of the first test pulse. f Two additional oocytes expressing alpha 4beta 4 receptors showed no recovery after 20-30 min wash. * Indicates significance (p < 0.05), as compared with data obtained in calcium-free media.

The much higher apparent nicotine affinity of alpha 4-containing subtypes, as compared with alpha 3-containing subtypes, is consistent with previous reports for heterologously expressed nAChRs from both chick (Hussy et al., 1994) and rat (Vibat et al., 1995). For alpha 3 subunit-containing receptors, our estimated EC50 values for nicotine were comparable to previously published data (for review, see Role, 1992; McGehee and Role, 1995). Little or no comparable data exist for alpha 4beta 4 receptors (Role, 1992). Our data for the alpha 4beta 2 receptor predict a lower apparent nicotine affinity (15 µM, calcium-containing solutions) than reports of heterologously expressed alpha 4beta 2 nAChRs from chick (0.8 µM; Bertrand et al., 1990), rat (0.3 µM; Vibat et al., 1995), and human (1.6 µM; Buisson et al., 1996).

Different time courses of desensitization of nAChR subtypes

Previous data show that nAChRs composed of different subunits desensitize with different time courses in response to various nicotinic agonists (Cachelin and Jaggi, 1991; Gross et al., 1991, 1995; Vibat et al., 1995). We have extended these findings, using nicotine as the agonist. Figure 2A shows representative responses of oocytes expressing four different nAChR subtypes to a 3 min application of nicotine at near half-maximal concentrations (see Fig. 1) in the presence of external calcium. Receptors containing beta 4 subunits desensitize slower than those containing beta 2 subunits (t = 6.2; p < 0.05). In most experiments the time course of desensitization for receptors containing beta 4 subunits was well described by a single exponential decay. In some oocytes, particularly those with larger peak currents, a faster "desensitizing" component was present in alpha 4beta 4-expressing and alpha 3beta 4-expressing oocytes (Fig. 2C). The fast component was calcium-dependent because it was eliminated, for the most part, when the same cells were examined in calcium-free media (Table 2). In contrast, the slower component of desensitization was unaffected by calcium (t = 0.21; p > 0.05; Fig. 2B, Table 2). These data are consistent with previous reports in which it was argued that a transient calcium-dependent Cl- current could be activated by certain neuronal nAChRs (Vernino et al., 1992; Seguela et al., 1993). On the other hand, beta 2-containing receptors generally required the sum of two exponentials for a good fit to the data in both the presence and absence of calcium, although the relative amplitude of the fast component was affected significantly by calcium (t = 76.5; p < 0.01; Fig. 2; Table 2). Thus beta 2-containing nAChRs have, in addition to a slow component of desensitization, an intrinsic fast desensitization process. Differences in the size of the fast "desensitizing" component of alpha 4beta 2 and alpha 3beta 2 receptors in calcium-free and calcium-containing medium potentially could reflect differences in the extent of activation of the endogenous Cl- current and/or differential modulation of the fast and slow components by external calcium ions.
Fig. 2. The time course of desensitization varies with nAChR subtype. A, Responses to brief (~3 min) applications of nicotine at near EC50 concentrations in calcium-containing media for oocytes injected with different subunit combinations. For comparison, the responses are normalized to their peaks. The time course of desensitization for responses obtained from oocytes expressing beta 4-containing receptors (left two traces) were well described by a single exponential component. For beta 2-containing receptors (right two traces), the decay phase was well described by the sum of two exponentials. B, Responses to 3 min applications of nicotine in calcium-free (left trace) and calcium-containing (right trace) media for an oocyte expressing alpha 4beta 4 receptors. The traces are normalized to the peak currents. The solid lines are single exponential functions fit to the desensitizing phase of the responses, and their associated time constants (tau s) are shown. C, Responses to 3 min applications of nicotine in calcium-free (left trace) and calcium-containing (right trace) media for an oocyte expressing alpha 3beta 4 receptors. The solid lines are single exponential functions fit to the desensitizing phase of the responses. In calcium-containing media the data were fit with two separate single exponentials, designated tau f and tau s. The exponential functions contained a steady-state component, which was constrained not to fall below baseline current. The final steady-state values were generally in the range of 0-20% peak current.
[View Larger Version of this Image (20K GIF file)]

Brief agonist applications do not provide sufficient data to characterize receptor desensitization fully (Katz and Thesleff, 1957; Feltz and Trautman, 1982). Moreover, the desensitization resulting from long applications of nanomolar concentrations of nicotine may reveal receptor subtype differences that are related more closely to mechanisms underlying nicotine dependency (Stolerman and Shoaib, 1991; Dani and Heinemann, 1996). With this in mind, we examined the subunit dependence of nAChR desensitization induced by low levels of nicotine. Because it is not possible to measure desensitization directly from the very small currents produced by such low agonist concentrations, desensitization was estimated from the nicotine-induced reduction in the current elicited by a brief (5-10 sec) test pulse of acetylcholine (ACh) near the half-maximal concentration for each receptor (Feltz and Trautman, 1982). The ACh test pulses were applied at sufficient time intervals (2-10 min, based on the particular subunit combination) so as not to induce any additional desensitization. The data were expressed as the fractional test current remaining with respect to the time of nicotine exposure. For those experiments in which nicotine induced some receptor activation, the fractional current remaining was calculated from the sum of both the nicotine- and ACh-induced currents. Estimation of desensitization in this manner leads to an underestimation of the extent of desensitization if the current induced by nicotine is a significant fraction of the total response. Large nicotine-induced currents were apparent only at higher agonist concentrations with certain receptor subtypes (e.g., alpha 3beta 4; see Fig. 4). In these cases only, both the rate of desensitization development and the magnitude of desensitization will be underestimated slightly.


Fig. 4. The time course and extent of desensitization are concentration-dependent. A, Plot of the peak amplitudes of the currents induced by ACh test pulses (100 µM) with respect to time before and during continuous perfusion with 1 µM (open squares), 10 µM (filled circles), or 30 µM (open circles) nicotine in oocytes expressing alpha 3beta 4 receptors. tau d is the time constant for a single exponential fit to the time course of desensitization. The arrowheads represent near-equilibrium conditions at which the magnitude of desensitization was estimated (see Fig. 5). B, Representative traces of currents induced by ACh test pulses before (control) and at the indicated times during incubation with either 1 µM (top traces) or 10 µM (bottom traces) nicotine. All data were obtained in calcium-free media.
[View Larger Version of this Image (21K GIF file)]

As shown in Figure 3, incubation of oocytes with nanomolar concentrations of nicotine (levels that produce little activation of any of the receptor subtypes; see Fig. 1) induces a profound desensitization of nAChRs. Differences in the time course of desensitization for different nAChR subtypes are immediately apparent and parallel the differences in desensitization observed with brief pulses (see Fig. 2). In our experiments, receptors with beta 4 subunits desensitized more slowly than those containing beta 2 subunits (t = 9.7; p < 0.05), irrespective of the presence or absence of calcium (Fig. 3). For all subunits the time course of desensitization could be described reasonably well by a single exponential fit (although see below), which allowed for a more quantitative comparison of desensitization kinetics. Table 1 shows that at concentrations of nicotine that produced a half-maximal block (see Fig. 5) the time constant for the development of desensitization varied considerably, from 4 min (alpha 3beta 2) to 45 min (alpha 3beta 4).


Fig. 3. The time course of desensitization is slow in receptors containing beta 4 subunits. A, Plot of the peak current amplitudes induced by an ACh test pulse with respect to time before and during continuous perfusion with either 300 or 100 nM nicotine in oocytes expressing either alpha 4beta 2 receptors (left) or alpha 4beta 4 (right) receptors, respectively, in calcium-containing (top traces) or calcium-free (bottom traces) media. tau  is the time constant for a single exponential fit to the desensitization time course. B, Representative traces of the ACh test pulses before (control) and at the indicated times after incubation with nicotine for individual alpha 4beta 2-expressing (bottom left) or alpha 4beta 4-expressing (bottom right) oocytes in calcium-free media.
[View Larger Version of this Image (26K GIF file)]


Fig. 5. alpha 4-containing nAChRs are desensitized by nanomolar concentrations of nicotine. A, Concentration-response plots of the ACh-induced fractional current remaining after chronic nicotine incubation in oocytes expressing alpha 3beta 2, alpha 3beta 4, alpha 4beta 2, or alpha 4beta 4 receptors. Some of the data were obtained by extrapolating the exponential fit to 60 min (alpha 3beta 4 and alpha 4beta 4) or 15-20 min (alpha 3beta 2 and alpha 4beta 2). The open and filled symbols represent data obtained in calcium-containing and calcium-free media, respectively. Each concentration data point represents between 1 and 10 measurements from separate oocytes. Solid lines are logistic fits to the mean of all the data obtained in calcium-free and calcium-containing media. Fits were constrained so that the maximal block could not exceed 100% and so that at infinitely low nicotine concentrations the block was zero. The half-maximal concentration for inhibition (IC50) by nicotine is shown for each nAChR subtype. B, Examples of the inhibition of the ACh test pulses by different concentrations of nicotine for two receptor subtypes, alpha 3beta 4 (top traces) and alpha 4beta 4 (bottom traces). Each pair of traces shows the current induced before nicotine incubation (con) and the current remaining after a 60 min incubation, with the concentration of nicotine indicated.   
[View Larger Version of this Image (25K GIF file)]

Potency of nicotine for desensitization of nAChRs

To compare more quantitatively the nicotine-induced desensitization of nAChR subtypes, we examined desensitization over a range of nicotine concentrations. Because the time course of desensitization development is concentration-dependent (Fig. 4) and subtype-dependent (see Fig. 3), different periods of nicotine incubation were required for each nAChR subtype to reach near-equilibrium conditions. Figure 4A shows that for the receptor with the slowest desensitization time course, alpha 3beta 4, a 60 min exposure was sufficient to produce ~90% desensitization even at low nicotine concentrations. Longer incubation times typically were not used to allow time for response recovery and to ensure that recovery reflected reversal of desensitization rather than de novo receptor synthesis (Peng et al., 1994; Hsu et al., 1995). In addition, for receptor subtypes that reached equilibrium faster (e.g., alpha 3beta 2), nicotine exposure was continued in some cases for up to 30 min to ensure that a slower component of desensitization was not present. Although we cannot exclude completely the possibility that very slow desensitization components exist, desensitization of these subunits by nicotine is complete, for the most part, within the first hour (see also Hsu et al., 1995).

In theory, other mechanisms distinct from desensitization, such as partial antagonism or channel block by nicotine, could explain the decrease in ACh-induced currents in the presence of nicotine. Partial antagonism seems unlikely, especially for beta 4-containing receptors, because the block developed and recovered slowly. Even at low concentrations a purely competitive nicotine effect would be expected to be instantaneous, for the most part. Because nicotine is not a very efficacious agonist at chick alpha 3beta 2 receptors (Wang et al., 1996) and given that this receptor subtype shows a relatively fast nicotine block, partial antagonism remains a possibility; however, nicotine does not seem to act as a partial antagonist at rat alpha 3beta 2 nAChRs (Hussy et al., 1994). A direct, use-dependent channel block by nicotine, although reported for neuronal nicotinic receptors, is also unlikely at such low agonist concentrations (Maconochie and Knight, 1992).

Once the time course of desensitization equilibrium was established, inhibition dose-response curves were constructed from the relative depression of an ACh test pulse induced during incubation with various nicotine concentrations (Fig. 5). The data were fit to a logistic equation from which the IC50 (half-maximal effective desensitizing concentration) for nicotine was estimated. In the present study we refer to the IC50 as the apparent affinity of nicotine for the desensitized state of the receptor. The receptor subtypes could be divided into two groups, based on these IC50 values. Similar to activation (see Fig. 1), nAChRs expressing alpha 4 subunits had a higher apparent affinity for the desensitized state, as compared with nAChRs containing alpha 3 subunits (t = 5.6; p < 0.05). There is an approximately linear relationship between the half-maximal concentrations of nicotine for activation and desensitization (Table 1). These data indicate that the time course of desensitization is not a good predictor of nicotine affinity for the desensitized state. For example, alpha 4beta 4 receptors, which have a slow desensitization onset, demonstrate the highest apparent nicotine affinity for the desensitized state. On the other hand, alpha 3beta 2 receptors, which have a fast onset, have a relatively low apparent desensitization affinity. At the highest concentrations of nicotine tested, all nAChR subtypes except alpha 3beta 2 receptors were desensitized completely; alpha 3beta 2 receptors were desensitized ~78% (Fig. 5).

Recovery from desensitization

After prolonged exposure to nicotine, the different nAChR subtypes recovered to pre-nicotine exposure values with different rates (Fig. 6). Differences in the time course of recovery from desensitization among subtypes were compared by fitting single exponentials to the recovery phase of the response after washout of 1 µM nicotine. Receptors containing alpha 4 subunits (i.e., nAChRs with a higher-affinity desensitized state) recovered more slowly from desensitization than those containing alpha 3 subunits (t = 21.2; p < 0.01). This result is not unexpected, because recovery ultimately involves an unbinding of agonist and a change in the receptor from desensitized to activatable; this is likely to be the slowest for the highest affinity receptor. Indeed, for alpha 4beta 4 receptors, recovery often was incomplete even with 2 hr washout (Fig. 6B). On the other hand, alpha 3beta 2 receptors recovered within a few minutes (Fig. 6C). Additionally, receptors containing beta 4 subunits (i.e., nAChRs in which the time course of desensitization development is slower) recovered more slowly than those containing beta 2 subunits (t = 8.4; p < 0.05; Fig. 6A). Thus, alpha 3beta 4 receptors show a rate of recovery intermediate of alpha 3beta 2 receptors and alpha 4beta 4 receptors.
Fig. 6. Time course of recovery from nicotine-induced desensitization is subunit-dependent. A, Histogram of the mean time constants for a single exponential fit to the time course of recovery from desensitization induced by 1 µM nicotine for a number of nAChR subtypes. Data from experiments in calcium-free and calcium-containing media were combined. The number of experiments for each subtype is indicated in parentheses. Recovery was estimated after nicotine incubation of 15-20 min (alpha 3beta 2 and alpha 4beta 2 receptors) and 60 min (alpha 3beta 4 and alpha 4beta 4 receptors). B, Plot of normalized peak current amplitudes (o---o) induced by a repetitively applied ACh test pulse (5 µM; 5 min intervals) with respect to time before, during (open bar), and after continuous perfusion with 300 nM nicotine in calcium-containing media for an oocyte expressing alpha 4beta 4 receptors. C, Plot of normalized peak amplitudes of currents (o---o) induced by a repetitively applied ACh test pulse (100 µM; 10 min intervals) with respect to time before, during (open bar), and after continuous perfusion with 3 µM nicotine in calcium-free media for an oocyte expressing alpha 3beta 2 receptors. The time constants (tau ) in B and C result from single exponential fits (solid line) to the time course of recovery from desensitization. The exponential fit assumed recovery to control values.
[View Larger Version of this Image (20K GIF file)]

The above analysis assumed a single exponential recovery from desensitization. This is a reasonable assumption for beta 4-containing receptors; however, it may be inaccurate for beta 2-containing receptors. Receptors containing beta 2 subunits require the sum of two components to describe the desensitization phase during a brief pulse (see Fig. 2). These data imply multiple desensitized states for these receptors (Feltz and Trautman, 1982; Boyd, 1987). Thus, it follows that recovery from desensitization also may have two components (Feltz and Trautman, 1982; Cachelin and Colquhoun, 1989; Lester and Dani, 1995).

Recovery from desensitization for muscle-type nAChRs has been shown to be influenced by calcium-dependent mechanisms (Hardwick and Parsons, 1996). Thus, it is possible that similar mechanisms control the recovery of neuronal nAChRs. Because of the long duration of recordings necessary to examine the slow recovery from desensitization at low concentrations of nicotine, we used, instead, a paired-pulse approach to test the influence of calcium on the recovery from desensitization. A single 3 min application of nicotine at near EC50 concentrations was followed at a known interval by a second test pulse of nicotine, and the fractional recovery from desensitization was estimated in both calcium-free and calcium-containing media (Fig. 7). To reduce variability, often we tested the same oocyte under both conditions. Our results indicate that calcium has little effect on recovery from desensitization of nAChRs, although for some subtypes, e.g., alpha 4beta 2, the rate of recovery may be enhanced in the presence of calcium (t = 31.1; p < 0.01).


Fig. 7. Subunit-specific differences in the recovery from desensitization. A, Paired-pulses of nicotine (10 µM) applied to an oocyte expressing alpha 4beta 2 receptors at an interpulse interval of 20 min. To account for differences in the relative amount of desensitization in calcium-containing and calcium-free media, we quantified recovery by measuring the fractional increase in the amplitude of the second pulse (I2) with respect to the amount of desensitization (I1) induced by a 3 min application of nicotine. B, Plot of the fractional recovery from desensitization at various interpulse intervals in the presence (open circles) or absence (filled circles) of added calcium. C, Histogram of the relative recovery from desensitization for each nAChR subtype in the presence or absence of calcium. The number of experiments for each subtype is indicated in parentheses. The interpulse intervals were 10 min for both alpha 4beta 4 receptors and alpha 4beta 2 receptors, 5 min for alpha 3beta 4 receptors, and 3 min for alpha 3beta 2 receptors. Individual oocytes expressing alpha 4beta 2 and alpha 3beta 2 receptors were measured in both calcium-free and calcium-containing media. Significant differences (p < 0.05) between the results obtained in the two conditions are indicated by the asterisk.
[View Larger Version of this Image (19K GIF file)]

The outcome of prolonged exposure to nicotine is determined initially by the balance between receptor activation and desensitization at a particular nicotine concentration. To illustrate how this balance varies for different nAChR subtypes, we have replotted the activation and desensitization curves (Figs. 1A, 5) on the same axes (Fig. 8). The concentration range in which the activation and desensitization curves overlap indicates a "window current" (Steinbach, 1990), a region over which nicotine always produces some nAChR channel activation, because desensitization will be incomplete. At tobacco-related concentrations (60-300 nM; Benowitz et al., 1989) the main effect of nicotine will be to desensitize nAChRs (see Table 1), thus reducing the population of receptors available for potential stimulation by endogenously released ACh (see Lester and Dani, 1995). However, for the higher affinity alpha 4 subunit-containing nAChRs, nicotine at these concentrations will produce some channel activation.


Fig. 8. Receptor activation and desensitization have subtype-specific overlapping concentration ranges. Shown are summary concentration-response plots for activation in calcium-containing media (filled symbols; solid lines) and for desensitization (open symbols) of four nAChR subtypes. For comparison, the logistic fits to the activation concentration-response curves obtained in calcium-free media are indicated with dashed lines.
[View Larger Version of this Image (27K GIF file)]

alpha 7 receptor desensitization and activation by nicotine

Although the above data demonstrate that alpha  and beta  subunits differentially influence the desensitization process, not all expressed nAChRs require beta  subunits for channel formation or, indeed, for desensitization (e.g., alpha 7 receptors; Couturier et al., 1990). For these receptors, desensitization characteristics must be determined solely by the alpha  subunit (see Revah et al., 1991). The demonstration that alpha 7-containing receptors mediate a presynaptic release of transmitter in the continuous presence of low concentrations of nicotine (McGehee et al., 1995; Gray et al., 1996) demands a detailed investigation of this subtype with respect to desensitization.

Figure 9 characterizes activation and desensitization for alpha 7 receptors. As described by others (Couturier et al., 1990; Revah et al., 1991; Seguela et al., 1993), alpha 7 nAChRs activate and desensitize rapidly to brief applications of high agonist concentrations (Fig. 9A). The dose-response relationship for nicotine reveals a relatively high EC50 (234 µM, calcium-free solutions), implying that alpha 7 receptors have a very low apparent affinity for nicotine. There was an approximately twofold shift in the EC50 to lower values in the presence of extracellular calcium ions (t = 9.4; p < 0.05) with little effect on maximal activation (Fig. 9B). Our EC50 values of 79 µM (3.6 mM calcium) and 90 µM (1.8 mM calcium) are slightly higher than those reported previously for human alpha 7 (49 µM; Gopalakrishnan et al., 1995), rat alpha 7 (~30 µM; Seguela et al., 1993), and chick alpha 7 (24 µM; Amar et al., 1993). Accounting for the decrease in single-channel conductance because of calcium (Mulle et al., 1992b; Amador and Dani, 1995), these data imply that calcium may increase both the affinity and efficacy of alpha 7 nAChRs (Galzi et al., 1996). Desensitization of alpha 7 receptors (and subsequent recovery from desensitization) at low concentrations of nicotine was rapid (Fig. 9C,D). However, in the absence of added calcium, desensitization was observed only for concentrations of nicotine above ~1 µM, setting it apart from the various alpha beta -paired nAChRs. In calcium-free media, the half-maximal concentration of nicotine for desensitization was 6 µM, the highest of all receptors tested (Fig. 9F). The addition of calcium significantly increased the effectiveness of nicotine to desensitize alpha 7-expressing receptors (IC50 = 1 µM; t = 18.5; p < 0.01), with little observable effect on the time course of desensitization (t = 2.7; p > 0.05; Fig. 9E,F). Thus, although alpha 7 receptors exhibit pronounced and rapid desensitization, much higher concentrations of nicotine are required.


Fig. 9. Homomeric alpha 7 receptors have low affinity for nicotine and rapid desensitization kinetics. A, Example of rapid desensitization induced by 200 µM nicotine in calcium-free media in an oocyte expressing alpha 7 receptors. The mean time constant (tau decay) resulting from a single exponential fit to the decay phase is indicated; the steady-state/peak current ratio was 0.023 ± 0.003 (10 observations from four cells). B, Concentration-response curves for nicotine-induced activation. The solid lines are logistic fits to the data sets. The EC50 values were 90 µM (n = 4) and 234 µM (n = 10) in the presence (open circles) or absence (closed circles) of calcium, respectively. The Hill coefficients for each were 1.1. C, Example of the currents induced by test pulses of ACh (100 µM) before (control), during continuous exposure, and after washout of 30 µM nicotine in calcium-free media. D, Plot of the peak test pulse amplitude (ACh, 100 µM) in two different oocytes expressing alpha 7 receptors before, during, and after incubation with 1 µM (open symbols) or 30 µM (closed symbols) nicotine in calcium-free media. E, Plot of the peak test pulse amplitude induced by ACh before, during, and after incubation of an alpha 7-expressing oocyte with a 10 min application of 5 µM nicotine in the presence (open circles) or absence (closed circles) of calcium. F, Concentration-response curve for nicotine-induced inhibition of the ACh test pulse in alpha 7 receptor-expressing oocytes. The solid lines are logistic fits, and the half-maximal concentrations for inhibition (IC50) by nicotine were 1.3 and 6.2 µM in the presence (open circles) or absence (closed circles) of calcium, respectively. The activation concentration-response curves obtained in the same conditions are shown (dashed lines) for comparison.
[View Larger Version of this Image (31K GIF file)]


DISCUSSION

Examination of a number of expressed nAChRs reveals patterns of functional contributions of particular alpha  and beta  subunits to the process of activation and desensitization. For heteromeric nAChRs we find that the alpha  subunit makes a significant contribution in determining the apparent nicotine affinity of the active and desensitized states of an nAChR; the beta  subunit makes a significant contribution in determining the overall time course of the desensitization development of an nAChR. In addition, we have demonstrated that external calcium ions, while producing subtle effects on the kinetics and apparent affinities of nicotine for activation and desensitization of the alpha beta nAChRs, do not alter the pattern of contributions of these various subunits. In contrast, for the homomeric alpha 7 nAChR, which displays faster kinetics and generally lower affinities for nicotine than the alpha beta pairs, we find that calcium increases the apparent affinity of nicotine for both the active and desensitized states.

Contribution of the alpha  subunit to activation of nAChRs by nicotine

Activation of various nAChR subtypes by nicotine produced straightforward results: alpha 4-containing receptors have higher apparent affinities for nicotine than alpha 3-containing receptors. Vibat et al. (1995) have observed a similar leftward shift in nicotine-induced dose-response curves on switching an alpha 4 subunit for an alpha 3 subunit in receptors containing rat beta 4 subunits. Chick and human alpha 4beta 2 receptors (Bertrand et al., 1990; Peng et al., 1994; Buisson et al., 1996) also are activated more potently by nicotine than are alpha 3beta 4 receptors (Hussy et al., 1994). If the alpha  subunit is the principal agonist-binding subunit, these results could indicate differences in agonist-binding affinity between these two alpha  subunits. However, this is likely an oversimplification. First, beta  subunits, as noted above, also affect the apparent affinity for some nAChR subtypes (Cachelin and Jaggi, 1991; Gross et al., 1991; Luetje and Patrick, 1991; Cohen et al., 1995), and, second, apparent affinity reflects both agonist binding and channel gating, so the observed subtype differences in concentration-response curves could represent differences in either affinity and/or efficacy. By examining the contribution of beta  subunits to the concentration-response relationship, Cohen et al. (1995) have argued that affinity differences cannot be explained by a change in efficacy and that, by analogy with muscle nAChRs, the binding site is likely to form between both alpha  and beta  subunits. This argument is supported by observations that antagonist sensitivity also is determined by both alpha  and beta  subunits (Cachelin and Rust, 1995; Harvey and Luetje, 1996). It is possible, therefore, that our activation results are attributable to the fortuitous selection of particular nAChRs.

alpha and beta  subunits contribute to nicotine-induced desensitization

The desensitization time course for nAChR subtypes, measured either directly from the current decay during brief nicotine applications or from the decrease in response to ACh test pulses in the presence low concentrations of nicotine, is influenced for the most part by the beta  subunit: fast for beta 2-containing nAChRs and slow for beta 4-containing nAChRs. These data extend previous findings for rat nAChRs (Cachelin and Jaggi, 1991; Hsu et al., 1995). Because homomeric alpha 7 receptors also desensitize, it is likely that the beta  subunit plays a modulatory, rather than a permissive role, in desensitization.

Studies investigating ACh desensitization of both chick and rat nAChRs, in which the beta  subunit was not varied, imply that the alpha  subunit also can influence the time course of desensitization (Gross et al., 1991; Vibat et al., 1995). Aside from agonist-dependent differences in desensitization, the contribution of alpha  subunits may be explained if one considers how desensitization was measured. For example, although short applications of nicotine demonstrate that alpha 3beta 2 receptors desensitize faster than alpha 4beta 2 receptors (Gross et al., 1991; Vibat et al., 1995), the reverse is true when the desensitization time course is followed by repetitive pulses (Vibat et al., 1995). Such differences may be explained if one considers a cyclical model for desensitization (Katz and Thesleff, 1957). In the continued presence of agonist, the time course of desensitization reflects the rates governing equilibration between the active/open and the desensitized states. These rates would be expected to be faster for alpha 3beta 2 receptors than alpha 4beta 2 receptors; hence alpha 3beta 2 receptors would desensitize faster in the continued presence of agonist. However, on removal of agonist, recovery can occur by the unbinding of agonist from the desensitized state (Dilger and Lui, 1993). Thus, if recovery in the absence of agonist is slow for alpha 4beta 2 receptors as compared with alpha 3beta 2 receptors, as we have observed, then desensitization measured by repetitive pulses (the agonist is absent in the interpulse interval) over a longer period of time would show a greater accumulation of alpha 4beta 2 receptors in the desensitized state (Vibat et al., 1995).

Relationship between nAChR channel properties and receptor regulation

Prolonged nicotine exposure leads to subtype-specific modulation (Schwartz and Kellar, 1985; Stolerman and Shoaib, 1991; Marks et al., 1993; Hsu et al., 1995; Dani and Heinemann, 1996). Because these changes arise at low nicotine concentrations, one must consider individual differences in nAChR behavior at these concentrations. A complete understanding of the cellular effects resulting from prolonged exposure to nicotine requires knowledge of the balance between activated and desensitized states of receptor subtypes (Steinbach, 1990; Balfour, 1994). All nAChRs studied desensitize at lower concentrations than they activate (Katz and Thesleff, 1957); however, for each receptor there is a concentration range over which desensitization is incomplete and activation has begun. Particularly for alpha 4beta 2 receptors, this window approximately corresponds to the estimated levels of nicotine found in the brain after tobacco smoke inhalation (Benowitz et al., 1989).

For certain nAChR subtypes, e.g., alpha 4beta 2 receptors, chronic nicotine exposure results in pronounced upregulation of receptor number (Flores et al., 1992; Peng et al., 1994; Gopalakrishnan et al., 1996). Because the desensitized state of alpha 4beta 2 receptors has high nicotine affinity (it is desensitized for the most part by 1 µM nicotine), this state may be the trigger for the increase in receptor number (Ochoa et al., 1990; Peng et al., 1994; Gopalakrishnan et al., 1996). This idea is supported by evidence that exposure to nAChR antagonists also induces an increase in receptor number; i.e., a nonactive state of the receptor is a sufficient stimulus (Collins et al., 1994; Peng et al., 1994; Gopalakrishnan et al., 1996). An accompanying increase in receptor sensitivity then could be a direct consequence of increased receptor number (Rowell and Wonnacott, 1990; Gopalakrishnan et al., 1996). However, others have observed a downregulation in receptor function (Marks et al., 1993; Collins et al., 1994; Peng et al., 1994). The relatively high activation affinity of alpha 4beta 2 receptors means that, although most receptors are desensitized by tobacco-related levels of nicotine, a continuous low level of activity remains. Prolonged low rates of synaptic activity have been associated with an NMDA-mediated calcium-dependent long-term depression of glutamatergic responses (Dudek and Bear, 1992; Mulkey and Malenka, 1992). An intriguing possibility is that functional downregulation of nAChRs is related to their high calcium permeability. The concept of an overlapping agonist concentration window for activation and desensitization could account for the dual up- and downregulation of alpha 4beta 2 receptor function (Peng et al., 1994; Gopalakrishnan et al., 1996); the precise agonist concentration would control the relative balance between active and desensitized receptor states.

Differences in regulation among nAChRs could be explained by subtype-specific nicotine sensitivities of both the desensitized and active receptor states. Studies on the homomeric alpha 7 receptor provide some support for this notion. The finding that nanomolar concentrations of nicotine can, via alpha 7-like presynaptic nAChRs, cause a continuous release of glutamate from synaptic terminals (McGehee et al., 1995; Gray et al., 1996) is consistent with the present observation that these concentrations of nicotine would cause little desensitization of alpha 7 receptors. The desensitization hypothesis for increases in nAChR number would predict that alpha 7 receptors should not be upregulated as readily as alpha 4beta 2 receptors. In fact, the number of alpha -bungarotoxin (alpha -BTX) binding sites, putatively formed from alpha 7 subunits (Couturier et al., 1990), can be upregulated by chronic nicotine treatment. However, relatively high concentrations of nicotine are required (Marks et al., 1983). At lower concentrations of nicotine (that result in increased alpha 4beta 2 receptor number), alpha 7/alpha -BTX receptors are unaffected (Marks et al., 1985; Collins et al., 1994).

It should be noted that some CNS nAChRs, including alpha 7, may contain more than a single type of alpha  or beta  subunit (Conroy et al., 1992; Anand et al., 1993; Ramirez-Latorre et al., 1996; Wang et al., 1996). Also, there may be some differences between nAChRs expressed in oocytes and mammalian cells (Peng et al., 1994; Wong et al., 1995; Buisson et al., 1996). Such differences may result in shifts in concentration-response curves and/or desensitization properties (Ramirez-Latorre et al., 1996; Wang et al., 1996). Regardless, knowledge of the subunit contribution to activation and desensitization is important for accurate predictions of the differential effects of tobacco-related levels of nicotine on CNS nAChRs.


FOOTNOTES

Received Dec. 30, 1996; revised April 18, 1997; accepted May 19, 1997.

  

This work was supported by United States Public Health Service (USPHS) National Institute of Neurological Disorders and Stroke Grant R29 NS31669 (R.A.J.L.), USPHS National Cancer Institute Grant CA13148 (M.W.Q.), and W. M. Keck Foundation Grant 931360. We thank Dr. David S. Weiss for helpful discussions and comments on this manuscript.

Correspondence should be addressed to Dr. Robin A. J. Lester, Department of Neurobiology, CIRC Room 560, University of Alabama at Birmingham, 1719 Sixth Avenue South, Birmingham, AL 35294-0021.



REFERENCES

  • Amador M, Dani JA (1995) Mechanism for modulation of nicotinic acetylcholine receptors that can influence synaptic transmission. J Neurosci 15:4525-4532[Abstract].
  • Amar M, Thomas P, Johnson C, Lunt GG, Wonnacott S (1993) Agonist pharmacology of the neuronal alpha 7 nicotinic receptor expressed in Xenopus oocytes. FEBS Lett 327:284-288[Web of Science][Medline].
  • Anand R, Conroy WG, Schoepfer R, Whiting P, Lindstrom J (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure. J Biol Chem 266:11192-11198[Abstract/Free Full Text].
  • Anand R, Peng X, Lindstrom J (1993) Homomeric and native alpha 7 acetylcholine receptors exhibit remarkably similar but non-identical pharmacological properties, suggesting that the native receptor is a heteromeric protein complex. FEBS Lett 327:241-246[Web of Science][Medline].
  • Balfour DJK (1994) Neural mechanisms underlying nicotine dependence. Addiction 89:1419-1423[Web of Science][Medline].
  • Benowitz NL, Porchet H, Jacob III P (1989) Nicotinic dependence and tolerance in man: pharmacokinetic and pharmacodynamic investigations. Prog Brain Res 79:279-287[Web of Science][Medline].
  • Bertrand D, Ballivet M, Rungger D (1990) Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes. Proc Natl Acad Sci USA 87:1993-1997[Abstract/Free Full Text].
  • Boyd ND (1987) Two distinct kinetic phases of desensitization of acetylcholine receptors of clonal rat PC12 cells. J Physiol (Lond) 389:45-67[Abstract/Free Full Text].
  • Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, Bertrand D (1996) Human alpha 4beta 2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 16:7880-7891[Abstract/Free Full Text].
  • Cachelin AB, Colquhoun D (1989) Desensitization of the acetylcholine receptor of frog end-plates measured in a Vaseline-gap voltage clamp. J Physiol (Lond) 415:159-188[Abstract/Free Full Text].
  • Cachelin AB, Jaggi R (1991) beta subunits determine the time course of desensitization in rat alpha 3 neuronal nicotinic acetylcholine receptors. Pflügers Arch 419:579-582[Web of Science][Medline].
  • Cachelin AB, Rust G (1995) beta subunits codetermine the sensitivity of rat neuronal nicotinic receptors to antagonists. Pflügers Arch 429:449-451[Web of Science][Medline].
  • Clark PBS (1993) Nicotinic receptors in mammalian brain: localization and relation to cholinergic innervation. Prog Brain Res 98:77-83[Web of Science][Medline].
  • Cohen BN, Figl A, Quick MW, Labarca C, Davidson N, Lester HA (1995) Regions of beta 2 and beta 4 responsible for differences between the steady-state dose-response relationships of the alpha 3beta 2 and alpha 3beta 4 neuronal nicotinic receptors. J Gen Physiol 105:745-764[Abstract/Free Full Text].
  • Collins AC, Luo Y, Selvaag S, Marks MJ (1994) Sensitivity to nicotine and brain nicotinic receptors are altered by chronic nicotine and mecamylamine infusion. J Pharmacol Exp Ther 271:125-133[Abstract/Free Full Text].
  • Conroy WG, Vernallis AB, Berg DK (1992) The alpha 5 gene product assembles with multiple acetylcholine receptor subunits to form distinctive receptor subtypes in brain. Neuron 9:679-691[Web of Science][Medline].
  • Cooper C, Courturier S, Ballivet M (1991) Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor. Nature 350:235-238[Medline].
  • Couturier S, Bertrand D, Matter JM, Hernandez MC, Bertrand S, Millar N, Valera S, Barkas T, Ballivet M (1990) A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 5:847-856[Web of Science][Medline].
  • Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908[Web of Science][Medline].
  • Dilger JP, Lui Y (1993) Desensitization of acetylcholine receptors in BC3H-1 cells. Pflügers Arch 420:479-485.
  • Dineley-Miller K, Patrick J (1992) Gene transcripts for the nicotinic acetylcholine receptor subunit, beta 4, are distributed in multiple areas of the rat central nervous system. Mol Brain Res 16:339-344[Medline].
  • Dudek SM, Bear MF (1992) Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci USA 89:4363-4367[Abstract/Free Full Text].
  • Duvoisin RM, Deneris ES, Patrick J, Heinemann S (1989) The functional diversity of the neuronal nicotinic acetylcholine receptor is increased by a novel subunit beta 4. Neuron 3:487-496[Web of Science][Medline].
  • Feltz A, Trautmann A (1982) Desensitization at the frog neuromuscular junction: a biphasic process. J Physiol (Lond) 322:257-272[Abstract/Free Full Text].
  • Finney D (1971) In: Probit analysis, 3rd Ed. New York: Cambridge UP.
  • Flores CM, Rogers SW, Pabreza LA, Wolfe BB, Kellar KJ (1992) A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. J Pharmacol Exp Ther 41:31-37.
  • Galzi JL, Bertrand S, Corringer PJ, Changeux JP, Bertrand D (1996) Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor. EMBO J 15:5824-5832[Web of Science][Medline].
  • Gopalakrishnan M, Buisson B, Touma E, Giordano T, Campbell JE, Hu IC, Donnelly-Roberts D, Arneric SP, Bertrand D, Sullivan JP (1995) Stable expression and pharmacological properties of the human alpha 7 nicotinic acetylcholine receptor. Eur J Pharmacol 290:237-246[Web of Science][Medline].
  • Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, Sullivan JP (1996) Stable expression, pharmacologic properties, and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor. J Pharmacol Exp Ther 276:289-297[Abstract/Free Full Text].
  • Gray R, Rajan A, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716[Medline].
  • Gross B, Ballivet M, Rungger D, Bertrand D (1991) Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes: role of the alpha subunit in agonist sensitivity and desensitization. Pflügers Arch 419:545-551[Web of Science][Medline].
  • Hardwick JC, Parsons RL (1996) Activation of the protein phosphatase calcineurin during carbachol exposure decreases the extent of recovery from end-plate desensitization. J Neurophysiol 76:3609-3616[Abstract/Free Full Text].
  • Harvey SC, Luetje CW (1996) Determinants of competitive antagonist sensitivity on neuronal nicotinic receptor beta  subunits. J Neurosci 16:3798-3806[Abstract/Free Full Text].
  • Hussy N, Ballivet M, Bertrand D (1994) Agonist and antagonist effects of nicotine on chick neuronal receptors are defined by alpha  and beta  subunits. J Neurophysiol 72:1317-1326[Abstract/Free Full Text].
  • Hsu Y-N, Amin J, Weiss DS, Wecker L (1995) Sustained nicotine exposure differentially affects alpha 3beta 2 and alpha 4beta 2 neuronal nicotinic receptors expressed in Xenopus oocytes. J Neurochem 66:667-675[Web of Science][Medline].
  • Katz B, Thesleff S (1957) A study of the desensitization produced by acetylcholine at the motor end-plate. J Physiol (Lond) 138:63-80.
  • Lester RAJ, Dani JA (1995) Acetylcholine receptor desensitization induced by nicotine in rat medial habenula neurons. J Neurophysiol 74:195-206[Abstract/Free Full Text].
  • Luetje CW, Patrick JP (1991) Both alpha  and beta  subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci 11:837-845[Abstract].
  • Maconochie DJ, Knight DE (1992) A study of the bovine adrenal chromaffin nicotinic receptor using patch-clamp and concentration-jump techniques. J Physiol (Lond) 454:129-153[Abstract/Free Full Text].
  • Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:817-825[Free Full Text].
  • Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619-628[Abstract/Free Full Text].
  • Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermana-Borgmeyer I, Heinemann SF, Collins AC (1992) Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 12:2765-2784[Abstract].
  • Marks MJ, Grady SR, Collins AC (1993) Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266:1268-1276[Abstract/Free Full Text].
  • McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546[Web of Science][Medline].
  • McGehee DS, Role LW (1996) Presynaptic ionotropic receptors. Curr Opin Neurobiol 6:342-349[Web of Science][Medline].
  • McGehee DS, Heath MJ, Gelber S, Devay P, Role LW (1995) Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science 269:1692-1696[Abstract/Free Full Text].
  • Morris BJ, Hicks AA, Wisden W, Darlison MG, Hunt SP, Barnard EA (1990) Distinct regional expression of nicotinic acetylcholine receptor genes in chick brain. Mol Brain Res 7:305-315[Medline].
  • Mulkey RM, Malenka RC (1992) Mechanisms underlying induction of homosynaptic long-term depression in area CA1 of the hippocampus. Neuron 9:967-975[Web of Science][Medline].
  • Mulle C, Choquet D, Korn H, Changeux JP (1992a) Calcium influx through nicotinic receptor in rat central neurons: its relevance to cellular regulation. Neuron 8:135-143[Web of Science][Medline].
  • Mulle C, Lena C, Changeux JP (1992b) Potentiation of nicotinic receptor response by external calcium in rat central neurons. Neuron 8:937-945[Web of Science][Medline].
  • Ochoa ELM, Li L, McNamee MG (1990) Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol Neurobiol 4:251-287[Medline].
  • Peng X, Gerzanich V, Annad R, Whiting PJ, Lindstrom J (1994) Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol Pharmacol 46:523-530[Abstract].
  • Quick MW, Lester HA (1994) Methods for expression of excitability proteins in Xenopus oocytes. In: Methods in neurosciences (Conn PM, ed), pp 261-279. San Diego: Academic.
  • Ramirez-Latorre J, Yu CR, Qu X, Perin F, Karlin A, Role L (1996) Functional contributions of alpha 5 subunit to neuronal acetylcholine receptor channels. Nature 380:347-351[Medline].
  • Rathouz MM, Berg DK (1994) Synaptic-type acetylcholine receptors raise intracellular calcium levels in neurons by two mechanisms. J Neurosci 14:6935-6945[Abstract].
  • Revah F, Bertrand D, Galzi JL, Devillers-Thiery A, Mulle C, Hussy N, Bertrand S, Ballivet M, Changeux JP (1991) Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature 353:846-849[Medline].
  • Role LW (1992) Diversity in primary structure and function of neuronal nicotinic acetylcholine receptor channels. Curr Opin Neurobiol 2:254-262[Medline].
  • Role LW, Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085[Web of Science][Medline].
  • Rowell PP, Wonnacott S (1990) Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55:2105-2110[Web of Science][Medline].
  • Schwartz RD, Kellar KJ (1985) In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433[Web of Science][Medline].
  • Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW (1993) Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J Neurosci 13:596-604[Abstract].
  • Steinbach JH (1990) Mechanism of action of the nicotinic acetylcholine receptor. Ciba Found Symp 152:53-67[Medline].
  • Stolerman IP, Shoaib M (1991) The neurobiology of tobacco addiction. Trends Pharmacol Sci 12:467-473[Medline].
  • Vernino S, Amador M, Luetje CW, Patrick J, Dani JA (1992) Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron 8:127-134[Web of Science][Medline].
  • Vibat CRT, Lasalde JA, McNamee MG, Ochoa ELM (1995) Differential desensitization properties of rat neuronal nicotinic acetylcholine receptor subunit combinations expressed in Xenopus oocytes. Cell Mol Neurobiol 15:411-425[Web of Science][Medline].
  • Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, Swanson LW (1989) Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 284:314-355[Web of Science][Medline].
  • Wang F, Gerzanich V, Wells GB, Anand R, Peng X, Keyser K, Lindstrom J (1996) Assembly of human neuronal nicotinic receptor alpha 5 subunits with alpha 3, beta 2, and beta 4 subunits. J Biol Chem 271:17656-17665[Abstract/Free Full Text].
  • Whiting P, Lindstrom J (1988) Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci 8:3395-3404[Abstract].
  • Whiting PJ, Schoepfer R, Conroy WG, Gore MJ, Keyser KT, Shimasaki S, Esch F, Lindstrom JM (1991) Expression of nicotinic acetylcholine receptor subtypes in brain and retina. Mol Brain Res 10:61-70[Medline].
  • Wong ET, Holstad SG, Mennerick SJ, Hong SE, Zorumski CF, Isenberg KE (1995) Pharmacological and physiological properties of a putative ganglionic nicotinic receptor, alpha 3 beta 4, expressed in transfected eucaryotic cells. Mol Brain Res 28:101-109[Medline].
  • Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98[Web of Science][Medline].

Copyright ©1997 Society for Neuroscience   0270-6474/1997/175747-13$05.00/0



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T.-Y. Wu, C. M. Smith, S. M. Sine, and M. M. Levandoski
Morantel Allosterically Enhances Channel Gating of Neuronal Nicotinic Acetylcholine {alpha}3{beta}2 Receptors
Mol. Pharmacol., August 1, 2008; 74(2): 466 - 475.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. Mamede, K. Ishizu, M. Ueda, T. Mukai, Y. Iida, H. Kawashima, H. Fukuyama, K. Togashi, and H. Saji
Temporal Change in Human Nicotinic Acetylcholine Receptor After Smoking Cessation: 5IA SPECT Study
J. Nucl. Med., November 1, 2007; 48(11): 1829 - 1835.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Xu, W. Yang, G. Zhang, Q. Gu, and L.-Y. Lee
Calcium transient evoked by nicotine in isolated rat vagal pulmonary sensory neurons
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L54 - L61.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Wu, Q. Liu, K. Yu, J. Hu, Y.-P. Kuo, M. Segerberg, P. A. St John, and R. J. Lukas
Roles of nicotinic acetylcholine receptor {beta} subunits in function of human {alpha}4-containing nicotinic receptors
J. Physiol., October 1, 2006; 576(1): 103 - 118.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Xiao, H. Fan, J. L. Musachio, Z.-L. Wei, S. K. Chellappan, A. P. Kozikowski, and K. J. Kellar
Sazetidine-A, A Novel Ligand That Desensitizes {alpha}4beta2 Nicotinic Acetylcholine Receptors without Activating Them
Mol. Pharmacol., October 1, 2006; 70(4): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Hu, K. Lindenberger, G. Hu, H. Wang, R. J. Lukas, and J. Wu
Iptakalim as a Human Nicotinic Acetylcholine Receptor Antagonist
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 914 - 925.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. S. Gutkin, S. Dehaene, and J.-P. Changeux
A neurocomputational hypothesis for nicotine addiction
PNAS, January 24, 2006; 103(4): 1106 - 1111.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. Fonck, B. N. Cohen, R. Nashmi, P. Whiteaker, D. A. Wagenaar, N. Rodrigues-Pinguet, P. Deshpande, S. McKinney, S. Kwoh, J. Munoz, et al.
Novel Seizure Phenotype and Sleep Disruptions in Knock-In Mice with Hypersensitive {alpha}4* Nicotinic Receptors
J. Neurosci., December 7, 2005; 25(49): 11396 - 11411.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. C Klein and J. L Yakel
Paired-pulse potentiation of {alpha}7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurones
J. Physiol., November 1, 2005; 568(3): 881 - 889.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. A. Davis, J. R. James, S. J. Siegel, and T. J. Gould
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
J. Neurosci., September 21, 2005; 25(38): 8708 - 8713.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-P. Kuo, L. Xu, J. B. Eaton, L. Zhao, J. Wu, and R. J. Lukas
Roles for Nicotinic Acetylcholine Receptor Subunit Large Cytoplasmic Loop Sequences in Receptor Expression and Function
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 455 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. E. Gomez-Casati, P. A Fuchs, A. B. Elgoyhen, and E. Katz
Biophysical and pharmacological characterization of nicotinic cholinergic receptors in rat cochlear inner hair cells
J. Physiol., July 1, 2005; 566(1): 103 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Alkondon and E. X. Albuquerque
Nicotinic Receptor Subtypes in Rat Hippocampal Slices Are Differentially Sensitive to Desensitization and Early in Vivo Functional Up-Regulation by Nicotine and to Block by Bupropion
J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 740 - 750.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C.-H. Cho, W. Song, K. Leitzell, E. Teo, A. D. Meleth, M. W. Quick, and R. A. J. Lester
Rapid Upregulation of {alpha}7 Nicotinic Acetylcholine Receptors by Tyrosine Dephosphorylation
J. Neurosci., April 6, 2005; 25(14): 3712 - 3723.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Tsuneki, Y. You, N. Toyooka, S. Kagawa, S. Kobayashi, T. Sasaoka, H. Nemoto, I. Kimura, and J. A. Dani
Alkaloids Indolizidine 235B', Quinolizidine 1-epi-207I, and the Tricyclic 205B are Potent and Selective Noncompetitive Inhibitors of Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2004; 66(4): 1061 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci
Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio
J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, L. Cleemann, J. Lindstrom, and M. Morad
Differential Modulation of {beta}2 and {beta}4 Subunits of Human Neuronal Nicotinic Acetylcholine Receptors by Acidification
Mol. Pharmacol., August 1, 2004; 66(2): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. L. Parker, Y. Fu, K. McAllen, J. Luo, J. M. McIntosh, J. M. Lindstrom, and B. M. Sharp
Up-Regulation of Brain Nicotinic Acetylcholine Receptors in the Rat during Long-Term Self-Administration of Nicotine: Disproportionate Increase of the {alpha}6 Subunit
Mol. Pharmacol., March 1, 2004; 65(3): 611 - 622.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
R. Metherate
Nicotinic Acetylcholine Receptors in Sensory Cortex
Learn. Mem., January 1, 2004; 11(1): 50 - 59.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
V. I. Pidoplichko, J. Noguchi, O. O. Areola, Y. Liang, J. Peterson, T. Zhang, and J. A. Dani
Nicotinic Cholinergic Synaptic Mechanisms in the Ventral Tegmental Area Contribute to Nicotine Addiction
Learn. Mem., January 1, 2004; 11(1): 60 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K G Paradiso and J. H. Steinbach
Nicotine is highly effective at producing desensitization of rat {alpha}4{beta}2 neuronal nicotinic receptors
J. Physiol., December 15, 2003; 553(3): 857 - 871.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. B. Eaton, J.-H. Peng, K. M. Schroeder, A. A. George, J. D. Fryer, C. Krishnan, L. Buhlman, Y.-P. Kuo, O. Steinlein, and R. J. Lukas
Characterization of Human {alpha}4{beta}2-Nicotinic Acetylcholine Receptors Stably and Heterologously Expressed in Native Nicotinic Receptor-Null SH-EP1 Human Epithelial Cells
Mol. Pharmacol., December 1, 2003; 64(6): 1283 - 1294.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. Khiroug, R. Giniatullin, R. C. Klein, D. Fayuk, and J. L. Yakel
Functional Mapping and Ca2+ Regulation of Nicotinic Acetylcholine Receptor Channels in Rat Hippocampal CA1 Neurons
J. Neurosci., October 8, 2003; 23(27): 9024 - 9031.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. R. A. Wooltorton, V. I. Pidoplichko, R. S. Broide, and J. A. Dani
Differential Desensitization and Distribution of Nicotinic Acetylcholine Receptor Subtypes in Midbrain Dopamine Areas
J. Neurosci., April 15, 2003; 23(8): 3176 - 3185.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. Fitch, Y. Xiao, K. J. Kellar, and J. W. Daly
Membrane potential fluorescence: A rapid and highly sensitive assay for nicotinic receptor channel function
PNAS, April 15, 2003; 100(8): 4909 - 4914.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. L. Gentry, L. H. Wilkins Jr., and R. J. Lukas
Effects of Prolonged Nicotinic Ligand Exposure on Function of Heterologously Expressed, Human alpha 4beta 2- and alpha 4beta 4-Nicotinic Acetylcholine Receptors
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 206 - 216.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. J. Middlebrook, C. Martina, Y. Chang, R. J. Lukas, and D. DeLuca
Effects of Nicotine Exposure on T Cell Development in Fetal Thymus Organ Culture: Arrest of T Cell Maturation
J. Immunol., September 15, 2002; 169(6): 2915 - 2924.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Rush, A. Kuryatov, M. E. Nelson, and J. Lindstrom
First and Second Transmembrane Segments of alpha 3, alpha 4, beta 2, and beta 4 Nicotinic Acetylcholine Receptor Subunits Influence the Efficacy and Potency of Nicotine
Mol. Pharmacol., June 1, 2002; 61(6): 1416 - 1422.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. S. Broide, R. Salas, D. Ji, R. Paylor, J. W. Patrick, J. A. Dani, and M. De Biasi
Increased Sensitivity to Nicotine-Induced Seizures in Mice Expressing the L250T alpha 7 Nicotinic Acetylcholine Receptor Mutation
Mol. Pharmacol., March 1, 2002; 61(3): 695 - 705.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Abdrakhmanova, J. Dorfman, Y. Xiao, and M. Morad
Protons Enhance the Gating Kinetics of the alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor by Increasing Its Apparent Affinity to Agonists
Mol. Pharmacol., February 1, 2002; 61(2): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Fabian-Fine, P. Skehel, M. L. Errington, H. A. Davies, E. Sher, M. G. Stewart, and A. Fine
Ultrastructural Distribution of the {alpha}7 Nicotinic Acetylcholine Receptor Subunit in Rat Hippocampus
J. Neurosci., October 15, 2001; 21(20): 7993 - 8003.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. R. Genzen, W. Van Cleve, and D. S. McGehee
Dorsal Root Ganglion Neurons Express Multiple Nicotinic Acetylcholine Receptor Subtypes
J Neurophysiol, October 1, 2001; 86(4): 1773 - 1782.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. L. Meyer, Y. Xiao, and K. J. Kellar
Agonist Regulation of Rat alpha 3beta 4 Nicotinic Acetylcholine Receptors Stably Expressed in Human Embryonic Kidney 293 Cells
Mol. Pharmacol., September 1, 2001; 60(3): 568 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci., March 15, 2001; 21(6): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
T. Narahashi, C. P. Fenster, M. W. Quick, R. A. J. Lester, W. Marszalec, G. L. Aistrup, D. B. Sattelle, B. R. Martin, and E. D. Levin
Symposium Overview: Mechanism of Action of Nicotine on Neuronal Acetylcholine Receptors, from Molecule to Behavior
Toxicol. Sci., October 1, 2000; 57(2): 193 - 202.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. A. Ross, J. Y. F. Wong, J. J. Clifford, A. Kinsella, J. S. Massalas, M. K. Horne, I. E. Scheffer, I. Kola, J. L. Waddington, S. F. Berkovic, et al.
Phenotypic Characterization of an alpha 4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse
J. Neurosci., September 1, 2000; 20(17): 6431 - 6441.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. B. Aramakis, C. Y. Hsieh, F. M. Leslie, and R. Metherate
A Critical Period for Nicotine-Induced Disruption of Synaptic Development in Rat Auditory Cortex
J. Neurosci., August 15, 2000; 20(16): 6106 - 6116.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
T. Narahashi
Neuroreceptors and Ion Channels as the Basis for Drug Action: Past, Present, and Future
J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 1 - 26.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
M. M. Francis, R. W. Vazquez, R. L. Papke, and R. E. Oswald
Subtype-Selective Inhibition of Neuronal Nicotinic Acetylcholine Receptors by Cocaine Is Determined by the alpha 4 and beta 4 Subunits
Mol. Pharmacol., July 1, 2000; 58(1): 109 - 119.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Zia, A. Ndoye, T. X. Lee, R. J. Webber, and S. A. Grando
Receptor-Mediated Inhibition of Keratinocyte Migration by Nicotine Involves Modulations of Calcium Influx and Intracellular Concentration
J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 973 - 981.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Lu, M. J. Marks, and A. C. Collins
Desensitization of Nicotinic Agonist-Induced [3H]gamma -Aminobutyric Acid Release from Mouse Brain Synaptosomes Is Produced by Subactivating Concentrations of Agonists
J. Pharmacol. Exp. Ther., December 1, 1999; 291(3): 1127 - 1134.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
O. Salminen, T. Seppa, H. Gaddnas, and L. Ahtee
The Effects of Acute Nicotine on the Metabolism of Dopamine and the Expression of Fos Protein in Striatal and Limbic Brain Areas of Rats during Chronic Nicotine Infusion and Its Withdrawal
J. Neurosci., September 15, 1999; 19(18): 8145 - 8151.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
Q.-S. Liu and D. K. Berg
Extracellular Calcium Regulates Responses of Both alpha 3- and alpha 7-Containing Nicotinic Receptors on Chick Ciliary Ganglion Neurons
J Neurophysiol, September 1, 1999; 82(3): 1124 - 1132.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. P. Fenster, T. L. Whitworth, E. B. Sheffield, M. W. Quick, and R. A. J. Lester
Upregulation of Surface alpha 4beta 2 Nicotinic Receptors Is Initiated by Receptor Desensitization after Chronic Exposure to Nicotine
J. Neurosci., June 15, 1999; 19(12): 4804 - 4814.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. C. Perry, M. I. Dávila-García, C. A. Stockmeier, and K. J. Kellar
Increased Nicotinic Receptors in Brains from Smokers: Membrane Binding and Autoradiography Studies
J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1545 - 1552.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
J. Zhang, Y. Xiao, G. Abdrakhmanova, W. Wang, L. Cleemann, K.J. Kellar, and M. Morad
Activation and Ca2+ Permeation of Stably Transfected alpha 3/beta 4 Neuronal Nicotinic Acetylcholine Receptor
Mol. Pharmacol., June 1, 1999; 55(6): 970 - 981.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. R. McQuiston and D. V. Madison
Nicotinic Receptor Activation Excites Distinct Subtypes of Interneurons in the Rat Hippocampus
J. Neurosci., April 15, 1999; 19(8): 2887 - 2896.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. D. Milner and L. T. Landmesser
Cholinergic and GABAergic Inputs Drive Patterned Spontaneous Motoneuron Activity before Target Contact
J. Neurosci., April 15, 1999; 19(8): 3007 - 3022.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. P. Fenster, M. L. Beckman, J. C. Parker, E. B. Sheffield, T. L. Whitworth, M. W. Quick, and R. A. J. Lester
Regulation of alpha 4beta 2 Nicotinic Receptor Desensitization by Calcium and Protein Kinase C
Mol. Pharmacol., March 1, 1999; 55(3): 432 - 443.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. M. Aragay and M. W. Quick
Functional Regulation of Galpha 16 by Protein Kinase C
J. Biol. Chem., February 19, 1999; 274(8): 4807 - 4815.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. K. Mahata, M. Mahata, R. J. Parmer, and D. T. O'Connor
Desensitization of Catecholamine Release. THE NOVEL CATECHOLAMINE RELEASE-INHIBITORY PEPTIDE CATESTATIN (CHROMOGRANIN A344-364) ACTS AT THE RECEPTOR TO PREVENT NICOTINIC CHOLINERGIC TOLERANCE
J. Biol. Chem., January 29, 1999; 274(5): 2920 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. L. Aistrup, W. Marszalec, and T. Narahashi
Ethanol Modulation of Nicotinic Acetylcholine Receptor Currents in Cultured Cortical Neurons
Mol. Pharmacol., January 1, 1999; 55(1): 39 - 49.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. Sabey, K. Paradiso, J. Zhang, and J. H. Steinbach
Ligand Binding and Activation of Rat Nicotinic alpha 4beta 2 Receptors Stably Expressed in HEK293 Cells
Mol. Pharmacol., January 1, 1999; 55(1): 58 - 66.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
V. Gerzanich, F. Wang, A. Kuryatov, and J. Lindstrom
alpha 5 Subunit Alters Desensitization, Pharmacology, Ca++ Permeability and Ca++ Modulation of Human Neuronal alpha 3 Nicotinic Receptors
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 311 - 320.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
M. Zoli, C. Lena, M. R. Picciotto, and J.-P. Changeux
Identification of Four Classes of Brain Nicotinic Receptors Using beta 2 Mutant Mice
J. Neurosci., June 15, 1998; 18(12): 4461 - 4472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. Eddins, L. K. Lyford, J. W. Lee, S. A. Desai, and R. L. Rosenberg
Permeant but not impermeant divalent cations enhance activation of nondesensitizing alpha 7 nicotinic receptors
Am J Physiol Cell Physiol, April 1, 2002; 282(4): C796 - C804.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (157)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fenster, C. P.
Right arrow Articles by Lester, R. A. J.

-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-